Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
9.49
-0.01 (-0.11%)
Aug 14, 2025, 4:49 PM CET
-0.11%
Market Cap153.38M
Revenue (ttm)37.76M
Net Income (ttm)-39.13M
Shares Out16.16M
EPS (ttm)-2.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,152
Average Volume18,762
Open9.51
Previous Close9.50
Day's Range9.40 - 9.54
52-Week Range8.38 - 19.90
Beta0.44
RSI40.78
Earnings DateSep 12, 2025

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.